Webster Todd M, Herrell S Duke, Chang Sam S, Cookson Michael S, Baumgartner Roxelyn G, Anderson Laura W, Smith Joseph A
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765, USA.
J Urol. 2005 Sep;174(3):912-4; discussion 914. doi: 10.1097/01.ju.0000169455.25510.ff.
Laparoscopic prostatectomy, whether or not coupled with robotic assistance, is often considered less invasive than open radical retropubic prostatectomy (RRP). Minimal postoperative pain has been reported following robot assisted laparoscopic prostatectomy (RALP) but there have been few comparative studies with RRP. We compared perioperative narcotic use and patient reported pain in a prospective patient series.
Between June 2003 and May 2004, 314 patients underwent radical prostatectomy at our institution, including RALP in 159, RRP in 154 and conversion in 1. All patients were treated on a postoperative clinical pathway that included 30 mg ketorolac intravenously immediately postoperatively, followed by 15 mg intravenously every 6 hours. No regional anesthesia (epidural/spinal) narcotics or patient controlled analgesic pumps were used. All narcotic use was converted to morphine sulfate equivalents for purpose of analysis. A Likert scale of 0 to 10 was used to assess pain on the day of surgery, and on postoperative days 1 and 14.
The total mean morphine sulfate equivalent +/- SD in patients in the RALP and RRP groups was low and, when corrected for length of stay, it was not statistically different (22.41 +/- 1.13 vs 23.01 +/- 1.16 mg, p = 0.72). Mean Likert pain perception scores were low at all time points in the RALP and RRP groups but statistically lower on the day of surgery in the RALP cohort (2.05 +/- 1.99 vs 2.60 +/- 2.25, p = 0.027). Patient reported mean pain scores were almost identical for RALP vs RRP on postoperative days 1 (1.76 +/- 1.87 vs 1.73 +/- 1.77, p = 0.880) and 14 (2.51 +/- 1.91 vs 2.42 +/- 1.84, p = 0.722).
Perioperative narcotic use and patient reported pain are low regardless of the surgical approach used for radical prostatectomy. RALP did not provide a clinically meaningful decrease in pain compared with RRP, primarily because of the low pain scores reported in each group. Outcomes other than pain will ultimately determine the role of laparoscopic radical prostatectomy and RALP.
腹腔镜前列腺切除术,无论是否辅以机器人辅助,通常被认为比开放性耻骨后根治性前列腺切除术(RRP)侵入性更小。机器人辅助腹腔镜前列腺切除术(RALP)术后疼痛轻微,但与RRP的比较研究较少。我们在一个前瞻性患者系列中比较了围手术期麻醉药物的使用情况以及患者报告的疼痛情况。
2003年6月至2004年5月期间,314例患者在我院接受了根治性前列腺切除术,其中159例行RALP,154例行RRP,1例行中转手术。所有患者均按照术后临床路径进行治疗,术后立即静脉注射30mg酮咯酸,随后每6小时静脉注射15mg。未使用区域麻醉(硬膜外/脊髓)麻醉药物或患者自控镇痛泵。为了分析,所有麻醉药物的使用都换算成了硫酸吗啡当量。采用0至10的李克特量表评估手术当天、术后第1天和第14天的疼痛情况。
RALP组和RRP组患者的硫酸吗啡当量总均值±标准差较低,校正住院时间后,两组无统计学差异(22.41±1.13mg对23.01±1.16mg,p = 0.72)。RALP组和RRP组在所有时间点的李克特疼痛感知评分均较低,但RALP队列在手术当天的评分在统计学上更低(2.05±1.99对2.60±2.25,p = 0.027)。患者报告的RALP与RRP术后第1天(1.76±1.87对1.73±1.77,p = 0.880)和第14天(2.51±1.91对2.42±1.84,p = 0.722)的平均疼痛评分几乎相同。
无论采用何种手术方式进行根治性前列腺切除术,围手术期麻醉药物的使用和患者报告的疼痛程度都较低。与RRP相比,RALP在疼痛减轻方面并无临床意义上的显著差异,主要原因是每组报告的疼痛评分都较低。除疼痛外的其他结果最终将决定腹腔镜根治性前列腺切除术和RALP的作用。